Impact of a comprehensive heart failure management program on hospital readmission and functional status of patients with advanced heart failure

Journal of the American College of Cardiology

Volumn 30, Issue 3, 1997, Pages 725-732

  Fonarow, Gregg C ^a   Stevenson, Lynne W ^b   Walden, Julie A ^a   Livingston, Nancy A ^a   Steimle, Anthony E ^a   Hamilton, Michele A ^a   Moriguchi, Jaime ^a   Tillisch, Jan H ^a   Woo, Mary A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; WARFARIN;

ADULT; ARTICLE; FEMALE; FUNCTIONAL ASSESSMENT; HEART FAILURE; HEART FUNCTION; HOSPITAL ADMISSION; HOSPITAL COST; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT PLANNING;

EID: 0030959746     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(97)00208-8     Document Type: Review

References (40)

1. Ho KK, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure the Framingham Study . J Am Coll Cardiol. 22:(Suppl A):1993;6-13A.
2. O'Connell JB, Bristow MR. Economic impact of heart failure in the United States time for a different approach . J Heart Lung Transplant. 13:1994;S107-S112.
3. Ghali JK, Cooper R, Ford E. Trends in hospitalization rates for heart failure in the United States, 1973-1986 evidence for increasing population prevalence . Arch Intern Med. 150:1990;769-773.
4. Hlatky MA, Fleg JL, Hinton PC, et al. Physician practice in the management of congestive heart failure. J Am Coll Cardiol. 8:1986;966-970.
5. Fleg JL, Hinton PC, Lakatta EG, et al. Physician utilization of laboratory procedures to monitor outpatients with congestive heart failure. Arch Intern Med. 149:1989;393-396.
6. Mudge GH, Goldstein S, Addonizio LJ, et al. 24th Bethesda conference: cardiac transplantation Task Force 3: recipient guidelines/prioritization . J Am Coll Cardiol. 22:1993;21-31.
7. Stevenson LW, Steimle AE, Fonarow G, et al. Improvement in exercise capacity of candidates awaiting heart transplantation. J Am Coll Cardiol. 25:1995;163-170.
8. Pierpont GL, Francis GS. Medical management of terminal cardiomyopathy. J Heart Transplant. 2:1982;18-27.
9. Fonarow GC, Chelimsky-Fallick C, Stevenson LW, et al. Effect of direct vasodilation with hydralazine versus angiotensin-converting enzyme inhibition with captopril on mortality in advanced heart failure the Hy-C trial . J Am Coll Cardiol. 19:1992;842-850.
10. Natterson PD, Stevenson WG, Saxon LA, Middlekauff HR, Stevenson LW. Risk of arterial embolization in 224 patients awaiting cardiac transplantation. Am Heart J. 129:1995;564-570.
11. Stevenson LW. Tailored therapy before transplantation for treatment of advanced heart failure effective use of vasodilators and diuretics . J Heart Lung Transplant. 10:1991;468-476.
12. Hinkle LE Jr, Thaler HT. Clinical classification of cardiac deaths. Circulation. 65:1982;457-464.
13. Dixon EJ. BMDP Statistical Software. University of California Press, 1992.
14. Raia JJ Jr, Barone JA, Byerly WG, Lacy CR. Angiotensin-converting enzyme inhibitors a comparative review . Drug Intell Clin Pharm. 24:1990;506-525.
15. Rajfer SI. Perspective of the pharmaceutical industry on the development of new drugs for heart failure. J Am Coll Cardiol. 22:(Suppl A):1993;198A-200A.
16. Edep ME, Shah NB, Tateo I, Massie BM. Differences in practice patterns in managing of heart failure patients between cardiologists, family practitioners and internists [abstract]. J Am Coll Cardiol. 27:(Suppl):1996;367A.
17. Pouleur H, Rousseau MF, Oakley C, Ryden L. Difference in mortality between patients treated with captopril or enalapril in the Xamoterol in Severe Heart Failure Study. Am J Cardiol. 68:1991;71-74.
18. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 325:1991;293-302.
19. Effects of enalapril on mortality in severe congestive heart failure results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS) . N Engl J Med. 316:1987;1429-1435.
20. Dracup K, Baker DW, Dunbar SB, et al. Management of heart failure II. Counseling, education, and lifestyle modifications . JAMA. 272:1994;1442-1446.
21. Baker DW, Konstam MA, Bottorff M, Pitt B. Management of heart failure I. Pharmacologic treatment . JAMA. 272:1994;1361-1366.
22. Konstam M, Dracup K, Baker D, et al. Heart failure: evaluation and care of patients with left ventricular systolic dysfunction. Clinical Practice Guideline No. 11. Washington (D.C.): Agency for Health Care Policy and Research, 1994:1-25.
23. Ghali JK, Kadakia S, Cooper R, Ferlinz J. Precipitating factors leading to decompensation of heart failure traits among urban blacks . Arch Intern Med. 148:1988;2013-2016.
24. Vinson JM, Rich MW, Sperry JC, Shah AS, McNamara T. Early readmission of elderly patients with congestive heart failure. J Am Geriatr Soc. 38:1990;1290-1295.
25. Rosenberg S. Patient education leads to better care for heart patients. Health Serv Mental Health Admin Health Rep. 86:1971;793-802.
26. Mullen PD, Green LW, Persinger GS. Clinical trials of patient education for chronic conditions a comparative meta-analysis of intervention types . Prev Med. 14:1985;753-781.
27. McKelvie RS, Teo KK, McCartney N, Humen D, Montague T, Yusuf S. Effects of exercise training in patients with congestive heart failure a critical review . J Am Coll Cardiol. 25:1995;789-796.
28. Coats AJ, Adamopoulos S, Radaelli A, et al. Controlled trial of physical training in chronic heart failure exercise performance, hemodynamics, ventilation, and autonomic function . Circulation. 85:1992;2119-2131.
29. Bristow MR, Gilbert EM, Abraham W, et al. Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. Circulation. 94:1996;2807-2816.
30. Kahn KL, Rogers WH, Rubenstein LV, et al. Measuring quality of care with explicit process criteria before and after implementation of the DRG-based prospective payment system. JAMA. 264:1990;1969-1973.
31. Ashton CM, Kuykendall DH, Johnson ML, Wray NP, Wu L. The association between the quality of inpatient care and early readmission. Ann Intern Med. 122:1995;415-421.
32. Brophy JM, Deslauriers G, Boucher B, Rouleau JL. The hospital course and short term prognosis of patients presenting to the emergency room with decompensated congestive heart failure. Can J Cardiol. 9:1993;219-224.
33. Rich MW, Beckham V, Wittenberg C, Leven CL, Freedland KE, Carney RM. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med. 333:1995;1190-1195.
34. Graham GW, Pan Z, Havranek EP. Differences between cardiologists and primary care physicians in outpatient management of heart failure [abstract]. J Am Coll Cardiol. 27:1996;367A.
35. Stevenson LW, Braunwald E. Heart failure. In: Goldman L, Braunwald E, editors. Primary Cardiology. Philadelphia: WB Saunders, 1997. In press.
36. Rickenbacher PR, Trindade PT, Haywood GA, et al. Transplant candidates with severe left ventricular dysfunction managed with medical treatment characteristics and survival . J Am Coll Cardiol. 27:1996;1192-1197.
37. Kubo SH, Ormaza SM, Francis GS, et al. Trends in patient selection for heart transplantation. J Am Coll Cardiol. 21:1993;975-981.
38. Stevenson LW, Hamilton MA, Tillisch JH, et al. Decreasing survival benefit from cardiac transplantation for outpatients as the waiting list lengthens. J Am Coll Cardiol. 18:1991;919-925.
39. Kao W, McGee D, Liao Y, et al. Does heart transplantation confer additional benefit over medical therapy to patients who have waited >6 months for heart transplantation? J Am Coll Cardiol. 24:1994;1547-1551.
40. Stevenson LW, Bourge RC, Naftel DC, et al. Deterioration and death on the current waiting list a multicenter study of patients awaiting heart transplantation [abstract] . Circulation. 92:(Suppl I):1995;I-124.